Lv11
80 积分 2025-07-11 加入
肠促胰素类减重药物临床应用专家共识（2025版）
5小时前
已完结
“Treat to success”，指引2型糖尿病管理新方向
6小时前
已完结
国家基层肥胖症综合管理技术指南（2025）
1个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
1个月前
已完结
Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review
2个月前
已完结
Peripheral artery disease: epidemiology and global perspectives
2个月前
已完结
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2个月前
已完结
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
2个月前
已完结
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
3个月前
已完结
Weight loss before bariatric surgery and its impact on poor versus excellent outcomes at 2 years
3个月前
已完结
皖公网安备34019202002308
